Patients aged @-@ years with a primary diagnosis of recurrent MDD , a Montgomery-sberg Depression Rating Scale ( MADRS ) total score @ and a Clinical Global Impression-Severity ( CGI-S ) score @ were randomized ( @:@ ) to treatment with either vortioxetine or venlafaxine XR .